Page last updated: 2024-11-03

propafenone and Ataxia

propafenone has been researched along with Ataxia in 1 studies

Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.

Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.

Research Excerpts

ExcerptRelevanceReference
"Propafenone is an effective antiarrhythmic drug used widely for the treatment of supraventricular and ventricular arrhythmias."5.31Propafenone-induced ataxia: report of three cases. ( Odeh, M; Oliven, A; Seligmann, H, 2000)
"Propafenone is an effective antiarrhythmic drug used widely for the treatment of supraventricular and ventricular arrhythmias."1.31Propafenone-induced ataxia: report of three cases. ( Odeh, M; Oliven, A; Seligmann, H, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Odeh, M1
Seligmann, H1
Oliven, A1

Other Studies

1 other study available for propafenone and Ataxia

ArticleYear
Propafenone-induced ataxia: report of three cases.
    The American journal of the medical sciences, 2000, Volume: 320, Issue:2

    Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Ataxia; Atrial Fibrillation; Brain; Fem

2000